{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:33:17Z","timestamp":1767843197892,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jviromet.2024.115079","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:02:45Z","timestamp":1732662165000},"page":"115079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine"],"prefix":"10.1016","volume":"332","author":[{"given":"Sung-Sil","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Bessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry B.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2024.115079_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56169-5","article-title":"Hemagglutinin quantitative ELISA-based potency assay for trivalent seasonal influenza vaccine using group-specific universal monoclonal antibodies","volume":"9","author":"Chae","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2024.115079_bib2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","article-title":"Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants","author":"Hanlon","year":"1987","journal-title":"Lancet 1"},{"key":"10.1016\/j.jviromet.2024.115079_bib3","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.vaccine.2008.10.008","article-title":"Inactivated rotavirus vaccines: a priority for accelerated vaccine development","volume":"26","author":"Jiang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2024.115079_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/hv.4.2.5263","article-title":"Immunogenicity of a thermally inactivated rotavirus vaccine in mice","volume":"4","author":"Jiang","year":"2008","journal-title":"Hum. Vaccin"},{"key":"10.1016\/j.jviromet.2024.115079_bib5","first-page":"177","article-title":"Validation of an in-vitro method for Hepatitis B vaccine potency assay: specification setting","volume":"52","author":"Karimzadeh","year":"2010","journal-title":"Panminerva Med."},{"key":"10.1016\/j.jviromet.2024.115079_bib6","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2018.04.048","article-title":"VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines","volume":"36","author":"Kuck","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2024.115079_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105099","article-title":"Bivalent rotavirus VP4 * stimulates protective antibodies against common genotypes of human rotaviruses","volume":"25","author":"Luo","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jviromet.2024.115079_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113056","article-title":"Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant","volume":"494","author":"McAdams","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2024.115079_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam5434","article-title":"VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans","volume":"9","author":"Nair","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jviromet.2024.115079_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jviromet.2024.115079_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41598-017-18973-9","article-title":"Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice","volume":"8","author":"Resch","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2024.115079_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-022-00470-4","article-title":"Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies","volume":"7","author":"Sanyal","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.jviromet.2024.115079_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075677","article-title":"High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses","volume":"8","author":"Sehr","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2024.115079_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/hv.1.5.2126","article-title":"Correlation between mouse potency and in vitro relative potency for human papillomavirus Type 16 virus-like particles and Gardasil vaccine samples","volume":"1","author":"Shank-Retzlaff","year":"2005","journal-title":"Hum. Vaccin"},{"key":"10.1016\/j.jviromet.2024.115079_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","article-title":"Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand","volume":"165","author":"Su-Arehawaratana","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2024.115079_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/jcm.29.3.483-487.1991","article-title":"Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination","volume":"29","author":"Taniguchi","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2024.115079_bib17","unstructured":"USP 2013. Chapter <1033> Biological Assay Validation, USP Pharmacopeial Convention, Rockville, MD."},{"key":"10.1016\/j.jviromet.2024.115079_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/irv.12528","article-title":"Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays","volume":"12","author":"Vasudevan","year":"2018","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.jviromet.2024.115079_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4161\/21645515.2014.988553","article-title":"Inactivated human rotavirus vaccine induces heterotypic antibody response: correction and development of IgG avidity assay","volume":"11","author":"Velasquez","year":"2015","journal-title":"Hum. Vaccin Immunother."}],"updated-by":[{"DOI":"10.1016\/j.jviromet.2024.115100","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424002040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424002040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:01:30Z","timestamp":1736204490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093424002040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":19,"alternative-id":["S0166093424002040"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115079","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jviromet.2024.115100","asserted-by":"object"}]},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115079"}}